<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>JCAD &#187; Clinical Study Review</title>
	<atom:link href="http://www.jcadonline.com/category/article-categories/clinical-study-review/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.jcadonline.com</link>
	<description>The Journal of Clinical and Aesthetic Dermatology (JCAD)</description>
	<lastBuildDate>Thu, 19 Jan 2012 16:38:25 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Increasing Patient Adherence in Antifungal Infection Treatment Once-Daily Dosing of Sertaconazole</title>
		<link>http://www.jcadonline.com/increasing-patient-adherence-in-antifungal-infection-treatment-once-daily-dosing-of-sertaconazole/</link>
		<comments>http://www.jcadonline.com/increasing-patient-adherence-in-antifungal-infection-treatment-once-daily-dosing-of-sertaconazole/#comments</comments>
		<pubDate>Fri, 27 Feb 2009 09:59:28 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[02-2009 (February 2009)]]></category>
		<category><![CDATA[Clinical Study Review]]></category>
		<category><![CDATA[General]]></category>
		<category><![CDATA[(compliance or adherence) antimycotic]]></category>
		<category><![CDATA[adherence and daily dose]]></category>
		<category><![CDATA[adherence and dermatology]]></category>
		<category><![CDATA[adherence and once-daily dosing in the treatment of fungal infections.]]></category>
		<category><![CDATA[adherence is particularly important with antifungal agents.]]></category>
		<category><![CDATA[adherence more than 100 percent]]></category>
		<category><![CDATA[adherence to treatment grants]]></category>
		<category><![CDATA[anti fungul infectin treatment on online .com]]></category>
		<category><![CDATA[antifungal drugs adherence rate in superficial mycoses]]></category>
		<category><![CDATA[antifungal infection]]></category>
		<category><![CDATA[antifungal laser treatment ny]]></category>
		<category><![CDATA[antifungals patient education]]></category>
		<category><![CDATA[antimycotic treatment]]></category>
		<category><![CDATA[cancer associated thrombosis and patient adherence]]></category>
		<category><![CDATA[comparative study of 2% sertaconazole solution and cream formulations in patients with tinea corporis, tinea pedis interdigitalis, or a corresponding candidosis]]></category>
		<category><![CDATA[daily increasing infection]]></category>
		<category><![CDATA[daily reminder calls to improve compliance with antibiotics]]></category>
		<category><![CDATA[dermatofitosis protuberans]]></category>
		<category><![CDATA[dermatologist medicine for anti fungal]]></category>
		<category><![CDATA[dermatology studies for enhancing medication adherence]]></category>
		<category><![CDATA[dermatomycosis and nanoparticle]]></category>
		<category><![CDATA[dermatomycosis research]]></category>
		<category><![CDATA[dosage and indication of sertaconazole nitrate]]></category>
		<category><![CDATA[hydrocortisone 2.5% para el tratamiento de la rosacea facial .com]]></category>
		<category><![CDATA[improving patient compliance 2009 2010]]></category>
		<category><![CDATA[increasing adherence to therapeutic regimens]]></category>
		<category><![CDATA[increasing patient adherence in antifungal infection treatment]]></category>
		<category><![CDATA[increasing patient adherence in antifungal infection treatment once- daily dosing of sertaconazole.]]></category>
		<category><![CDATA[journal arzneimittelforschung 2009 editorial board]]></category>
		<category><![CDATA[journal arzneimittelforschung editorial board]]></category>
		<category><![CDATA[lipogranuloma miconazole]]></category>
		<category><![CDATA[madurella]]></category>
		<category><![CDATA[medication adherence and antifungals]]></category>
		<category><![CDATA[medication compliance in dermatology]]></category>
		<category><![CDATA[moccasin sertaconazole]]></category>
		<category><![CDATA[non adherence to antifungals]]></category>
		<category><![CDATA[patient adherence logs]]></category>
		<category><![CDATA[patient adherence services spain]]></category>
		<category><![CDATA[patient education for antifungals]]></category>
		<category><![CDATA[presentation about patient adherence to medication during clinical trials]]></category>
		<category><![CDATA[protocol examples clinical trial treat superficial mycosis -fungoides]]></category>
		<category><![CDATA[psychology dermatomycosis of patients]]></category>
		<category><![CDATA[sertaconazole adherance]]></category>
		<category><![CDATA[sertaconazole cream 2% without prescription]]></category>
		<category><![CDATA[sertaconazole cream amazon]]></category>
		<category><![CDATA[sertaconazole france]]></category>
		<category><![CDATA[sertaconazole in treatment of fungal infection 2011]]></category>
		<category><![CDATA[sertaconazole pharmacokinetic]]></category>
		<category><![CDATA[sertaconazole pharmacokinetics]]></category>
		<category><![CDATA[sertaconazole vs clotrimazole]]></category>
		<category><![CDATA[sertraconazole for seborrheic dermatitis]]></category>
		<category><![CDATA[sponsors lookt to improve adherence and retention clinical trials]]></category>
		<category><![CDATA[tinea pedis nitric oxide]]></category>
		<category><![CDATA[trichophyton rubrum clotrimazole vs. sertaconazole]]></category>

		<guid isPermaLink="false">http://nearmyth.com/jcad/?p=774</guid>
		<description><![CDATA[Jeffrey M. Weinberg, MD Department of Dermatology, St. Luke’s–Roosevelt Hospital Center and Beth Israel Medical Center, New York, New York Disclosure: Dr. Weinberg is a speaker for and receives clinical research grants from OrthoNeutrogena. Editorial services provided by: Ann Braden Johnson, PhD, medical writer, and Medisys Health Communications, LLC. Supported by an educational grant from [...]]]></description>
		<wfw:commentRss>http://www.jcadonline.com/increasing-patient-adherence-in-antifungal-infection-treatment-once-daily-dosing-of-sertaconazole/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

